Cresset Asset Management’s Applied Therapeutics APLT Stock Holding History

Cresset Asset Management’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,091	Closed	-$1.71K	–	1661
2025 Q4	$1.71K	Hold	17,091	–	–	﹤0.01%	1657
2025 Q3	$10.3K	Buy	+17,091	New	+$8.05K	﹤0.01%	1566

Cresset Asset Management's APLT Position: Q1 2026 in Review

Cresset Asset Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 17,091 shares — an estimated $1.71K sold.

Cresset Asset Management first reported a position in APLT in Q3 2025 and held it in 2 quarters. The position peaked at $10.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Cresset Asset Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Cresset Asset Management sold 17,091 Applied Therapeutics shares in Q1 2026, an estimated $1.71K.
Cresset Asset Management first reported a position in Applied Therapeutics in Q3 2025 and held it in 2 quarters.
Cresset Asset Management's Applied Therapeutics position peaked at $10.3K in Q3 2025.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.